[HTML][HTML] Oral delivery of proteins and peptides: Challenges, status quo and future perspectives

Q Zhu, Z Chen, PK Paul, Y Lu, W Wu, J Qi - Acta Pharmaceutica Sinica B, 2021 - Elsevier
Proteins and peptides (PPs) have gradually become more attractive therapeutic molecules
than small molecular drugs due to their high selectivity and efficacy, but fewer side effects …

Pathogenesis of celiac disease and other gluten related disorders in wheat and strategies for mitigating them

N Sharma, S Bhatia, V Chunduri, S Kaur… - Frontiers in …, 2020 - frontiersin.org
Wheat is a major cereal crop providing energy and nutrients to the billions of people around
the world. Gluten is a structural protein in wheat, that is necessary for its dough making …

A review of advanced oral drug delivery technologies facilitating the protection and absorption of protein and peptide molecules

BF Choonara, YE Choonara, P Kumar… - Biotechnology …, 2014 - Elsevier
The oral delivery of proteins and peptides is a dynamic research field despite the numerous
challenges limiting their effective delivery. Successful oral delivery of proteins and peptides …

Duodenal bacteria from patients with celiac disease and healthy subjects distinctly affect gluten breakdown and immunogenicity

A Caminero, HJ Galipeau, JL McCarville, CW Johnston… - Gastroenterology, 2016 - Elsevier
Background & Aims Partially degraded gluten peptides from cereals trigger celiac disease
(CD), an autoimmune enteropathy occurring in genetically susceptible persons …

Claudin-2 as a mediator of leaky gut barrier during intestinal inflammation

J Luettig, R Rosenthal, C Barmeyer, JD Schulzke - Tissue barriers, 2015 - Taylor & Francis
The epithelial tight junction determines the paracellular water and ion movement in the
intestine and also prevents uptake of larger molecules, including antigens, in an …

[HTML][HTML] Celiac disease: role of the epithelial barrier

M Schumann, B Siegmund, JD Schulzke… - Cellular and molecular …, 2017 - Elsevier
In celiac disease (CD) a T-cell–mediated response to gluten is mounted in genetically
predisposed individuals, resulting in a malabsorptive enteropathy histologically highlighted …

Nanocarriers transport across the gastrointestinal barriers: the contribution to oral bioavailability via blood circulation and lymphatic pathway

D Wang, Q Jiang, Z Dong, T Meng, F Hu, J Wang… - Advanced Drug Delivery …, 2023 - Elsevier
Oral administration is the preferred route of drug delivery in clinical practice due to its
noninvasiveness, safety, convenience, and high patient compliance. The gastrointestinal …

The gut microbiota in celiac disease and probiotics

R Chibbar, LA Dieleman - Nutrients, 2019 - mdpi.com
Celiac disease (CeD) is an immune-mediated enteropathy, and unique in that the specific
trigger is known: gluten. The current mainstay of therapy is a gluten-free diet (GFD). As novel …

Single cell transcriptomic analysis of the immune cell compartment in the human small intestine and in Celiac disease

N Atlasy, A Bujko, ES Bækkevold, P Brazda… - Nature …, 2022 - nature.com
Celiac disease is an autoimmune disorder in which ingestion of dietary gluten triggers an
immune reaction in the small intestine leading to destruction of the lining epithelium. Current …

Co-factors, microbes, and immunogenetics in celiac disease to guide novel approaches for diagnosis and treatment

EF Verdu, D Schuppan - Gastroenterology, 2021 - Elsevier
Celiac disease (CeD) is a frequent immune-mediated disease that affects not only the small
intestine but also many extraintestinal sites. The role of gluten proteins as dietary triggers …